BioCentury | Jul 2, 2020
Finance
SK becomes Korea’s third-largest public healthcare company after $800M IPO
...disorder and epilepsy. SK’s IPO follows two biotech debuts in Korea last month. Diagnostics company Gencurix Inc....
...SCM Lifescience (KOSDAQ:298060) raised $154.3 million on June 17. Elizabeth S. Eaton, Staff Writer SK Biopharmaceuticals Co. Ltd. Gencurix Inc. SCM...
...SCM Lifescience (KOSDAQ:298060) raised $154.3 million on June 17. Elizabeth S. Eaton, Staff Writer SK Biopharmaceuticals Co. Ltd. Gencurix Inc. SCM...
